| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/02/2023 | 63.93% | HC Wainwright & Co. | → $2 | Reiterates | → Buy |
| 11/09/2022 | 227.87% | Ascendiant Capital | → $4 | Initiates Coverage On | → Buy |
| 06/30/2022 | 63.93% | HC Wainwright & Co. | → $2 | Initiates Coverage On | → Buy |
What is the target price for NRX Pharmaceuticals (NRXP)?
The latest price target for NRX Pharmaceuticals (NASDAQ: NRXP) was reported by HC Wainwright & Co. on February 2, 2023. The analyst firm set a price target for $2.00 expecting NRXP to rise to within 12 months (a possible 63.93% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for NRX Pharmaceuticals (NRXP)?
The latest analyst rating for NRX Pharmaceuticals (NASDAQ: NRXP) was provided by HC Wainwright & Co., and NRX Pharmaceuticals reiterated their buy rating.
When is the next analyst rating going to be posted or updated for NRX Pharmaceuticals (NRXP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NRX Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NRX Pharmaceuticals was filed on February 2, 2023 so you should expect the next rating to be made available sometime around February 2, 2024.
Is the Analyst Rating NRX Pharmaceuticals (NRXP) correct?
While ratings are subjective and will change, the latest NRX Pharmaceuticals (NRXP) rating was a reiterated with a price target of $0.00 to $2.00. The current price NRX Pharmaceuticals (NRXP) is trading at is $1.22, which is within the analyst's predicted range.